| dc.contributor.author | Ghffari, Maryam | en_US |
| dc.contributor.author | Asadi, Milad | en_US |
| dc.contributor.author | Shanaehbandi, Dariush | en_US |
| dc.contributor.author | Bornehdeli, Soghra | en_US |
| dc.contributor.author | Sadeghzadeh, Mahsa | en_US |
| dc.contributor.author | Mohammad Reza Khani, Haniye | en_US |
| dc.contributor.author | Ghasembaglou, Shahram | en_US |
| dc.date.accessioned | 1399-07-08T17:57:53Z | fa_IR |
| dc.date.accessioned | 2020-09-29T17:57:53Z | |
| dc.date.available | 1399-07-08T17:57:53Z | fa_IR |
| dc.date.available | 2020-09-29T17:57:53Z | |
| dc.date.issued | 2020-05-01 | en_US |
| dc.date.issued | 1399-02-12 | fa_IR |
| dc.date.submitted | 2019-10-23 | en_US |
| dc.date.submitted | 1398-08-01 | fa_IR |
| dc.identifier.citation | Ghffari, Maryam, Asadi, Milad, Shanaehbandi, Dariush, Bornehdeli, Soghra, Sadeghzadeh, Mahsa, Mohammad Reza Khani, Haniye, Ghasembaglou, Shahram. (2020). Aberrant Expression of miR-103, miR-184, miR-378, miR-497 and miR-506 in Tumor Tissue from Patients with Oral Squamous Cell Carcinoma Regulates the Clinical Picture of the Patients. Asian Pacific Journal of Cancer Prevention, 21(5), 1311-1315. doi: 10.31557/APJCP.2020.21.5.1311 | en_US |
| dc.identifier.issn | 1513-7368 | |
| dc.identifier.issn | 2476-762X | |
| dc.identifier.uri | https://dx.doi.org/10.31557/APJCP.2020.21.5.1311 | |
| dc.identifier.uri | http://journal.waocp.org/article_89059.html | |
| dc.identifier.uri | https://iranjournals.nlai.ir/handle/123456789/33180 | |
| dc.description.abstract | Background: This study aimed to evaluate the expression patterns of miR-103, miR-184, miR-378, miR497 and in squamous cell carcinoma (SCC) of the tongue and to be compared with normal peripheral tissues. Methods: Tumor and marginal tissues were obtained from 50 patients with OSCC. After RNA extraction, expression level of miR-103, miR-184, miR-378, miR497, and miR506 was estimated using SYBR green master mix and real-time quantitative PCR. Results: It was observed that, there was no detectable difference in expression level of miR-103 between tumoral and marginal tissues. However, expression level of miR-184, and miR-378 showed significant increase in tumor tissue samples compared to marginal tissue samples. MiR-497 and miR-506 demonstrated considerable decrease in tumoral cells in comparison with peripheral tissues. Moreover, the expression level of miRNAs was associated with clinicopathological features of the patients. Conclusions: Our data indicated that miR-184, miR-378, miR-497, and miR-506 can be used as a potential diagnostic and prognostic biomarker in OSCC. Nevertheless, more studies are needed to confirm this claim.<br /> | en_US |
| dc.format.extent | 420 | |
| dc.format.mimetype | application/pdf | |
| dc.language | English | |
| dc.language.iso | en_US | |
| dc.publisher | West Asia Organization for Cancer Prevention (WAOCP) | en_US |
| dc.relation.ispartof | Asian Pacific Journal of Cancer Prevention | en_US |
| dc.relation.isversionof | https://dx.doi.org/10.31557/APJCP.2020.21.5.1311 | |
| dc.subject | oral squamous cell carcinoma | en_US |
| dc.subject | miR-184 | en_US |
| dc.subject | miR-378 | en_US |
| dc.subject | MiR-497 | en_US |
| dc.subject | miR-506 | en_US |
| dc.subject | Molecular Medicine | en_US |
| dc.title | Aberrant Expression of miR-103, miR-184, miR-378, miR-497 and miR-506 in Tumor Tissue from Patients with Oral Squamous Cell Carcinoma Regulates the Clinical Picture of the Patients | en_US |
| dc.type | Text | en_US |
| dc.type | Research Articles | en_US |
| dc.contributor.department | Tuberculosis and Lung Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. | en_US |
| dc.contributor.department | Tuberculosis and Lung Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. | en_US |
| dc.contributor.department | Tuberculosis and Lung Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. | en_US |
| dc.contributor.department | Immunology Research
Center, Tabriz University of Medical Sciences, Tabriz, Iran. | en_US |
| dc.contributor.department | Immunology Research
Center, Tabriz University of Medical Sciences, Tabriz, Iran. | en_US |
| dc.contributor.department | Immunology Research
Center, Tabriz University of Medical Sciences, Tabriz, Iran. | en_US |
| dc.contributor.department | Immunology Research
Center, Tabriz University of Medical Sciences, Tabriz, Iran. | en_US |
| dc.citation.volume | 21 | |
| dc.citation.issue | 5 | |
| dc.citation.spage | 1311 | |
| dc.citation.epage | 1315 | |
| nlai.contributor.orcid | 0000-0002-4806-1086 | |
| nlai.contributor.orcid | 0000-0001-7846-2908 | |
| nlai.contributor.orcid | 0000-0002-0449-0607 | |
| nlai.contributor.orcid | 0000-0002-5513-4175 | |
| nlai.contributor.orcid | 0000-0003-2440-0052 | |
| nlai.contributor.orcid | 0000-0002-2217-9940 | |
| nlai.contributor.orcid | 0000-0003-2340-3972 | |